Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.

Thirty women were randomized in a double-blind, placebo-controlled study to receive either norfloxacin, 200 mg orally daily at bedtime, or placebo for the prevention of recurrent bladder infection. Subjects were followed monthly to monitor compliance and symptoms, for urine culture and periurethral...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Nicolle, L E, Harding, G K, Thompson, M, Kennedy, J, Urias, B, Ronald, A R
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 1989
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176057/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2675752/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.7.1032
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!